Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Gallbladder cancer in Chile: Pathologic characteristics of survival and prognostic factors: analysis of 1,366 cases.

Roa I, Ibacache G, Muñoz S, de Aretxabala X.

Am J Clin Pathol. 2014 May;141(5):675-82. doi: 10.1309/AJCPQT3ELN2BBCKA.

PMID:
24713738
2.

Gallbladder cancer in a high risk area: morphological features and spread patterns.

Roa I, Araya JC, Villaseca M, Roa J, de Aretxabala X, Ibacache G.

Hepatogastroenterology. 1999 May-Jun;46(27):1540-6.

PMID:
10430291
3.

Surgical treatment of patients with T2 gallbladder carcinoma invading the subserosal layer.

Chijiiwa K, Nakano K, Ueda J, Noshiro H, Nagai E, Yamaguchi K, Tanaka M.

J Am Coll Surg. 2001 May;192(5):600-7.

PMID:
11333097
4.

Clinicopathological study of depth of subserosal invasion in patients with pT2 gallbladder carcinoma.

Sasaki R, Uesugi N, Itabashi H, Fujita T, Takeda Y, Hoshikawa K, Takahashi M, Funato O, Nitta H, Sugai T, Kanno S, Saito K.

J Surg Oncol. 2005 Nov 1;92(2):83-8.

PMID:
16231372
5.

[Prognostic analysis of T1 and T2 stage gallbladder cancer with invasion within the gallbladder wall].

Hou CS, Xu Z, Zhang TL, Peng Y, Ling XF, Wang LX, Zhou XS.

Zhonghua Wai Ke Za Zhi. 2006 Dec 1;44(23):1620-3. Chinese.

PMID:
17359693
6.

Carcinoma of the gallbladder: patterns of presentation, prognostic factors and survival rate. An 11-year single centre experience.

D'Hondt M, Lapointe R, Benamira Z, Pottel H, Plasse M, Letourneau R, Roy A, Dagenais M, Vandenbroucke-Menu F.

Eur J Surg Oncol. 2013 Jun;39(6):548-53. doi: 10.1016/j.ejso.2013.02.010. Epub 2013 Mar 21.

PMID:
23522952
7.

[Gallbladder cancer: trend and risk distribution in Chile].

Andia K M, Gederlini G A, Ferreccio R C.

Rev Med Chil. 2006 May;134(5):565-74. Epub 2006 Jun 19. Spanish.

8.

Clinical significance of wall invasion pattern of subserosa-invasive gallbladder carcinoma.

Okada K, Kijima H, Imaizumi T, Hirabayashi K, Matsuyama M, Yazawa N, Dowaki S, Tobita K, Ohtani Y, Tanaka M, Inokuchi S, Makuuchi H.

Oncol Rep. 2012 Nov;28(5):1531-6. doi: 10.3892/or.2012.1971. Epub 2012 Aug 10.

10.

[Mortality due to gallbladder cancer: retrospective analysis in three Chilean hospitals].

Gabrielli M, Hugo S, Domínguez A, Baez S, Venturelli A, Puga M, Díaz A, Jarufe N, Ferreccio C.

Rev Med Chil. 2010 Nov;138(11):1357-64. doi: /S0034-98872010001200003. Epub 2011 Jan 27. Spanish.

11.

[Is gallbladder cancer a disease with bad prognosis?].

Roa I, de Aretxabala X, Roa J, Araya JC, Villaseca M, Guzmán P, Burgos L.

Rev Med Chil. 2002 Nov;130(11):1295-302. Spanish.

PMID:
12587514
12.

Analysis of the relationships between clinicopathologic factors and survival in gallbladder cancer following surgical resection with curative intent.

Yang XW, Yang J, Li L, Man XB, Zhang BH, Shen F, Wu MC.

PLoS One. 2012;7(12):e51513. doi: 10.1371/journal.pone.0051513. Epub 2012 Dec 31.

13.

Curative resection in potentially resectable tumours of the gallbladder.

de Aretxabala XA, Roa IS, Burgos LA, Araya JC, Villaseca MA, Silva JA.

Eur J Surg. 1997 Jun;163(6):419-26.

PMID:
9231853
14.

Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC).

Duffy A, Capanu M, Abou-Alfa GK, Huitzil D, Jarnagin W, Fong Y, D'Angelica M, Dematteo RP, Blumgart LH, O'Reilly EM.

J Surg Oncol. 2008 Dec 1;98(7):485-9. doi: 10.1002/jso.21141.

PMID:
18802958
15.

[The pathological findings in patients reoperated on for gallbladder cancer].

Roa I, Aray JC, de Aretxabala X, Wistuba I, Burgos L.

Rev Med Chil. 1990 Feb;118(2):153-7. Spanish.

PMID:
2152714
16.

[DNA content and survival in subserous gallbladder carcinoma].

Roa I, de Aretxabala X, Fuentealba P, Cabrera ME, Araya JC, Roa J.

Rev Med Chil. 2004 Jul;132(7):794-800. Spanish.

PMID:
15379325
17.

Depth of subserosal invasion predicts long-term survival after resection in patients with T2 gallbladder carcinoma.

Wakai T, Shirai Y, Yokoyama N, Ajioka Y, Watanabe H, Hatakeyama K.

Ann Surg Oncol. 2003 May;10(4):447-54.

PMID:
12734095
18.

ERCC1 (excision repair cross-complementing 1) expression in pT2 gallbladder cancer is a prognostic factor.

Roa I, de Aretxabala X, Lantadilla S, Munoz S.

Histol Histopathol. 2011 Jan;26(1):37-43. doi: 10.14670/HH-26.37.

PMID:
21117025
19.

Gallbladder cancer, management of early tumors.

de Aretxabala X, Roa I, Burgos L.

Hepatogastroenterology. 1999 May-Jun;46(27):1547-51. Review.

PMID:
10430292
20.

[Incipient gallbladder carcinoma. Clinical and pathological study and prognosis in 196 cases].

Roa I, de Aretxabala X, Araya JC, Villaseca M, Roa J, Guzmán P.

Rev Med Chil. 2001 Oct;129(10):1113-20. Spanish.

PMID:
11775337

Supplemental Content

Support Center